Search Videos by Topic or Participant
Browse by Series:

Bundled Payment Models for Cancer-Related Costs

Panelists: Andrew L. Pecora, MD, FACP, CPE, JTCC
Published: Monday, Apr 27, 2015
For High-Definition, Click

Cancer medication is expensive and complicated to deliver, which contributes to the rapid rise of healthcare costs, explains Andrew L. Pecora, MD, FACP, CPE. In response to this exponential growth, he says, payers have started to implement a bundled payment design. In this model, wasting resources on unnecessary care is avoided without depriving the patient of needed care.

The Oncology Care Model, initiated by the Center for Medicare & Medicaid Innovation office of the Centers for Medicare & Medicaid Services, is one approach being tested. Cigna, Regional Cancer Care Associates, and UnitedHealthcare, are piloting approaches to rein in costs through incentives and other strategies, adds Pecora. Implementing these strategies comes with challenges, such as shifting the focus from cutting costs to improving quality, he says.
 
Slider Left
Slider Right
For High-Definition, Click

Cancer medication is expensive and complicated to deliver, which contributes to the rapid rise of healthcare costs, explains Andrew L. Pecora, MD, FACP, CPE. In response to this exponential growth, he says, payers have started to implement a bundled payment design. In this model, wasting resources on unnecessary care is avoided without depriving the patient of needed care.

The Oncology Care Model, initiated by the Center for Medicare & Medicaid Innovation office of the Centers for Medicare & Medicaid Services, is one approach being tested. Cigna, Regional Cancer Care Associates, and UnitedHealthcare, are piloting approaches to rein in costs through incentives and other strategies, adds Pecora. Implementing these strategies comes with challenges, such as shifting the focus from cutting costs to improving quality, he says.
 
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Key Questions for the Use of Immunotherapy Throughout the Disease Continuum for NSCLC in an Era of Rapid DevelopmentSep 29, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing GlioblastomaSep 29, 20182.0
Publication Bottom Border
Border Publication
x